Heptares Therapeutics Ltd, BioPark, Broadwater Road, Welwyn Garden City, Hertfordshire, AL7 3AX, UK.
LeadXpro, Park InnovAARE, 5232, Villigen, Switzerland.
Sci Rep. 2018 Jan 8;8(1):41. doi: 10.1038/s41598-017-18570-w.
Here we report an efficient method to generate multiple co-structures of the A G protein-coupled receptor (GPCR) with small-molecules from a single preparation of a thermostabilised receptor crystallised in Lipidic Cubic Phase (LCP). Receptor crystallisation is achieved following purification using a low affinity "carrier" ligand (theophylline) and crystals are then soaked in solutions containing the desired (higher affinity) compounds. Complete datasets to high resolution can then be collected from single crystals and seven structures are reported here of which three are novel. The method significantly improves structural throughput for ligand screening using stabilised GPCRs, thereby actively driving Structure-Based Drug Discovery (SBDD).
在这里,我们报告了一种从单个热稳定化的脂质立方相(LCP)结晶受体制剂中生成 A G 蛋白偶联受体(GPCR)与小分子的多个共结构的有效方法。通过使用低亲和力“载体”配体(茶碱)进行纯化来实现受体结晶,然后将晶体浸泡在含有所需(更高亲和力)化合物的溶液中。然后可以从单个晶体中收集完整的高分辨率数据集,这里报告了其中七个结构,其中三个是新的。该方法显著提高了使用稳定化 GPCR 进行配体筛选的结构通量,从而积极推动基于结构的药物发现(SBDD)。